Loading...

Stay current with insights from our analysts and industry updates. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.

Technology to benefit Singapore seniors

Image

07-Oct-15 Tablets and senior-friendly applications will soon benefit 25 senior activity centers in Singapore. IDA, A*STAR, NTUC Health and St Luke’s Eldercare have agreed to work together to identify challenges faced by seniors and carry out technical trials at identified eldercare facilities. [image: Healthcare Innovation]

Read More

China to build 100 hospitals, clinics in Africa

Image

07-Oct-15 The Chinese government will build 100 hospitals and clinics across Africa as part of a plan to improve health systems. "Learning from the EVD [Ebola Virus Disease] crisis, Chinese and African leaders in the health sectors fully support a new, well-funded, and functional international response system to manage future pandemics," said South Africa's Health Minister Aaron Motsoaledi. [image: CP Africa]

Read More

China's doctors urge more hypertension intervention

Image

30-Sep-15 Experts in China are urging more intensive management of hypertension in the nation, where 330 million people are affected by the illness. As in the US, guidelines in China recommend a maximum systolic pressure of 140. But a maximum of 120 could help save lives of over 50s with at least one additional risk factor, a US study has found. [image: China Daily]

Read More

Japan university to provide telemedicine facilities in India

Image

06-Oct-15 Kyushu University in Japan has collaborated with Jawaharlal Institute of Postgraduate Medical Education & Research (Jipmer) to provide telemedicine facilities in the field of surgical gastroenterology through video conferencing. Jipmer was designated a regional resource centre for telemedicine for South India in 2013. [image: ET Healthworld]

Read More

China’s high cancer drug prices create a market in Hong Kong

Image

09-Oct-15 Many treatments, including Herceptin and Gilead Sciences’ Sovaldi for hepatitis C, are either unavailable or more expensive in China than elsewhere. Aside from the lower price, visitors to Hong Kong from the mainland also prefer to buy their medicine there because they believe it is less likely to be counterfeit. [image: Bloomberg Business]

Read More